V. Giner

2.2k total citations
87 papers, 1.2k citations indexed

About

V. Giner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, V. Giner has authored 87 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in V. Giner's work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Research Studies (23 papers) and Lung Cancer Diagnosis and Treatment (16 papers). V. Giner is often cited by papers focused on Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Research Studies (23 papers) and Lung Cancer Diagnosis and Treatment (16 papers). V. Giner collaborates with scholars based in Spain, Belgium and France. V. Giner's co-authors include Ernesto Bragulat, António Coca, Alejandro de la Sierra, Esteban Poch, Daniel González, Jean‐Paul Sculier, M.C. Berchier, Josep Redón, Jean Klášterský and J. Lecomte and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

V. Giner

81 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Giner Spain	20	404	349	252	245	192	87	1.2k
Olufemi J. Ogunbiyi Nigeria	19	456 1.1×	311 0.9×	257 1.0×	196 0.8×	227 1.2×	70	1.8k
Azmi Nabulsi United States	11	288 0.7×	377 1.1×	210 0.8×	771 3.1×	177 0.9×	18	1.8k
Jennifer Sung United States	22	356 0.9×	231 0.7×	162 0.6×	452 1.8×	127 0.7×	46	1.6k
Carlo Rugiu Italy	22	143 0.4×	199 0.6×	156 0.6×	120 0.5×	181 0.9×	66	1.3k
G. Buccianti Italy	19	121 0.3×	239 0.7×	383 1.5×	168 0.7×	157 0.8×	49	1.7k
Rhonda Arthur United States	19	378 0.9×	130 0.4×	132 0.5×	127 0.5×	207 1.1×	45	1.1k
Yejin Mok United States	19	236 0.6×	193 0.6×	352 1.4×	130 0.5×	189 1.0×	64	1.4k
V. Beral United Kingdom	15	490 1.2×	166 0.5×	194 0.8×	269 1.1×	147 0.8×	21	1.7k
Naim Ata Türkiye	18	217 0.5×	101 0.3×	213 0.8×	222 0.9×	89 0.5×	95	1.1k
Yoon‐Ok Ahn South Korea	17	169 0.4×	218 0.6×	71 0.3×	71 0.3×	115 0.6×	48	1.1k

Countries citing papers authored by V. Giner

Since Specialization

Citations

This map shows the geographic impact of V. Giner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Giner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Giner more than expected).

Fields of papers citing papers by V. Giner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Giner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Giner. The network helps show where V. Giner may publish in the future.

Co-authorship network of co-authors of V. Giner

This figure shows the co-authorship network connecting the top 25 collaborators of V. Giner. A scholar is included among the top collaborators of V. Giner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Giner. V. Giner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mora‐Luján, José María, María Dolores Martín Escalante, V. Giner, et al.. (2024). Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2?. Revista Clínica Española (English Edition). 225(2). 57–69.

Jover, Francisco, et al.. (2024). Impact of Implementing an Antimicrobial Stewardship Program for Optimizing Antibiotic Treatment in Gram-negative Bacilli Bacteremia. Infection and Chemotherapy. 56(3). 351–351.

Giner, V., Francisco Pomares, José A. Quesada, et al.. (2022). C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19. Biomedicines. 10(6). 1393–1393. 7 indexed citations

Wikman‐Jorgensen, Philip, et al.. (2020). Enzyme replacement therapy for the treatment of Hunter disease: A systematic review with narrative synthesis and meta-analysis. Molecular Genetics and Metabolism. 131(1-2). 206–210. 10 indexed citations

Giner, V., Lorenzo Fácila, Sergio Martínez‐Hervás, et al.. (2019). ¿Han influido el algoritmo de prescripción de la Administración y las guías de manejo de la dislipemia de la ACC/AHA 2013 en el manejo de la dislipemia? Proyecto MEJORA-LO CV. Revista Clínica Española. 220(5). 282–289. 1 indexed citations

Sculier, Jean‐Paul, Jean‐Jacques Lafitte, Thierry Berghmans, et al.. (2018). A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer. Lung Cancer. 117. 32–37. 8 indexed citations

Pallarés‐Carratalá, Vicente, et al.. (2016). Overview of guidelines for the management of dyslipidemia: EU perspectives. Vascular Health and Risk Management. Volume 12. 357–369. 13 indexed citations

Sanfélix‐Genovés, José, Gabriel Sanfélix‐Gimeno, Salvador Peiró, et al.. (2012). Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort. Osteoporosis International. 24(3). 1045–1055. 32 indexed citations

Sanfélix‐Genovés, José, et al.. (2010). The population-based prevalence of osteoporotic vertebral fracture and densitometric osteoporosis in postmenopausal women over 50 in Valencia, Spain (the FRAVO Study). Bone. 47(3). 610–616. 55 indexed citations

10.

Berghmans, Thierry, P. Van Houtte, Marianne Paesmans, et al.. (2008). A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer. Lung Cancer. 64(2). 187–193. 22 indexed citations

11.

Sculier, Jean‐Paul, J.J. Lafitte, Marianne Paesmans, et al.. (2007). Chemotherapy improves low performance status lung cancer patients. European Respiratory Journal. 30(6). 1186–1192. 20 indexed citations

12.

Berchier, M.C., Thierry Berghmans, Benoît Colinet, et al.. (2007). European Lung Cancer Working Party Clinical Practice Guidelines. Small Cell Lung Cnacer: IV. Limited disease. 2(2). 74–82. 1 indexed citations

13.

Giner, V., et al.. (2006). Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease. Clinical Rheumatology. 26(6). 971–972. 38 indexed citations

14.

Giner, V., et al.. (2003). Thrombocytopenia Associated With Levodopa Treatment. Archives of Internal Medicine. 163(6). 735–735. 10 indexed citations

15.

Giner, V., Esteban Poch, Ernesto Bragulat, et al.. (2000). Renin-Angiotensin System Genetic Polymorphisms and Salt Sensitivity in Essential Hypertension. Hypertension. 35(1). 512–517. 100 indexed citations

16.

Sculier, Jean‐Paul, Marianne Paesmans, Jean‐Jacques Lafitte, et al.. (1999). Prognostic factors analysis for response to chemotherapy and survival in a prospective cohort of patients with unresectable locoregional non small cell lung cancer initially treated by induction chemotherapy. Clinical & Translational Oncology. 1(2). 92–100. 2 indexed citations

17.

Jp, Sculier, Marianne Paesmans, J Thiriaux, et al.. (1998). Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.. Journal of Clinical Oncology. 16(4). 1388–1396. 24 indexed citations

18.

Sculier, Jean‐Paul, M Paesmans, G. Bureau, et al.. (1996). Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.. Journal of Clinical Oncology. 14(8). 2337–2344. 54 indexed citations

19.

Sculier, Jean‐Paul, Marianne Paesmans, Michel Richez, et al.. (1996). Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC). Lung Cancer. 16(1). 21–33. 24 indexed citations

20.

Sculier, Jean‐Paul, M Paesmans, P Libert, et al.. (1994). Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Journal of Cancer. 30(9). 1342–1347. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact